Entry
Name
Surlorian (USAN/INN)
Formula
C18H19NO3S
Exact mass
329.1086
Mol weight
329.41
Structure
Mol file KCF file DB search
Remark
Efficacy
Ryanodine receptor stabilizer
Comment
Treatment of cardiac and skeletal muscle genetic disorders such as Catecholaminergic Polymorphic Ventricular Tachycardia and RYR1-related myopathies. Treatment of heart failure.
Target
Pathway
hsa04261 Adrenergic signaling in cardiomyocytes
Brite
Target-based classification of drugs [BR:br08310 ]
Ion channels
Voltage-gated ion channels
Ryanodine receptors (RYR)
RYR
D13172 Surlorian (USAN/INN)
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 23
1 C8x C 5.3200 -14.9100
2 C8y C 5.3200 -16.3100
3 C8x C 6.5100 -17.0100
4 C8y C 7.7700 -16.3100
5 C8y C 7.7700 -14.9100
6 C8x C 6.5100 -14.2100
7 S2x S 8.8900 -14.0000
8 C1x C 10.2200 -14.3500
9 C1x C 10.8500 -15.6100
10 N1y N 10.2200 -16.8700
11 C1x C 8.8900 -17.1500
12 O2a O 4.1047 -17.0051
13 C1a C 2.9163 -16.3123
14 C1b C 11.0754 -17.9783
15 C8y C 12.4598 -17.9680
16 C8x C 13.1785 -19.1916
17 C8x C 14.5785 -19.1810
18 C8y C 15.2694 -17.9634
19 C8x C 14.5507 -16.7399
20 C8x C 13.1507 -16.7504
21 C6a C 16.6694 -17.9634
22 O6a O 17.3787 -19.1914
23 O6a O 17.3555 -16.7750
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 8 9 1
8 9 10 1
9 7 8 1
10 4 11 1
11 5 7 1
12 10 11 1
13 2 12 1
14 12 13 1
15 10 14 1
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
24 21 22 1
25 21 23 2